Articul8 launches Bivia to bring domain-specific decision intelligence to enterprise AI agents LegalOn Technologies, the AI Contract Review Leader, Announces Expansion into the United States
Daniel Lewis joins as US CEO SAN FRANCISCO & TOKYO–(BUSINESS WIRE)–LegalOn Technologies (“LegalOn”), the leading…
Qorus and Accenture Announce Winners of 2022 Banking Innovation Awards
Awards celebrate the best new ideas and practices transforming banking BARCELONA & PARIS & NEW…
500 Global and Sanabil Investments announce Batch 4 of the Sanabil 500 MENA Seed Accelerator Program
15 companies will present live at Demo Day on December 4th at the Four Seasons…
Kazakhstan: TotalEnergies Implements its Energy Transition Strategy
TotalEnergies Sells its Interest in the Dunga Oil Field and Progresses Towards the Implementation of…
Thales Addresses Inclusivity With Its ‘Voice Payment Card’
A payment innovation that brings autonomy and convenience to visually impaired people Based on its…
PM Factory Netherlands Deploys Mavenir’s Cloud-Native Packet Gateway to Power its MVNO Solution Set
Mavenir’s cloud-native Packet Gateway enables PM Factory to offer voice & data interconnect services over…
BenevolentAI to Present at 41st Annual J.P. Morgan Healthcare Conference
LONDON–(BUSINESS WIRE)–BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it…
ThunderSoft Joins the Amazon SageMaker Ready Program
LAS VEGAS–(BUSINESS WIRE)–ThunderSoft, announced today it has joined the Amazon SageMaker Ready Program. This designation…
Universal Robina Corporation Selects Blue Yonder to Digitally Transform Planning Capabilities
Leading Filipino consumer food and beverage product company to implement Blue Yonder’s Luminate Planning solutions…
RAPT Therapeutics to Present FLX475 Phase 1/2 Data at the European Society for Medical Oncology (ESMO) Immuno-Oncology Annual Congress
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”…
Viracta Therapeutics Announces Preliminary Dose-Ranging Data from the Phase 1b/2 Trial of Nana-val in Advanced Epstein-Barr Virus-Positive (EBV+) Solid Tumors at the ESMO Immuno-Oncology Congress
Data from first two dose levels of Nana-val in patients with EBV+ recurrent/metastatic nasopharyngeal carcinoma…
Achilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022
– Durable partial response (PR) and stable disease (SD) achieved in heavily pre-treated non-small cell…
Fully Charged Wuling Motors Sets Sail On Completion of the Restructuring of New Energy Business
HONG KONG, Dec 1, 2022 – (ACN Newswire) – It was recently known to us…
KB Home Announces the Grand Opening of Legacy at Highland, a New-home Community in Clovis, California
Homebuilder offers personalized, new homes in a highly desirable Fresno-area location, affordably priced from the…
Cognigy Achieves AWS Conversational AI Competency Distinction
DÜSSELDORF, Germany & SAN FRANCISCO–(BUSINESS WIRE)–#cognigy—Cognigy announced today that it has achieved the Amazon Web…
AWS and Slalom Expand Next-Generation Strategic Collaboration
Renewed agreement supports global expansion, strengthens Slalom’s collaboration with AWS Professional Services, and positions both…
Revive Therapeutics Ltd. Announces Offering of Up to $5 Million
TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — REVIVE THERAPEUTICS LTD. (CSE: RVV; OTCQB: RVVTF) (“Revive”…
Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022
LOS ANGELES, Nov. 30, 2022 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) — On November 23, 2022,…
Baudax Bio Announces 1-for-40 Reverse Stock Split
MALVERN, Pa., Nov. 30, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company…
Intellia Therapeutics Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…